Hong Kong stocks surging | Four Rings Pharmaceuticals (00460.HK) up more than 6% as two new drugs independently developed by its subsidiary Xuanzhu Biological for two indications are approved for market listing application.

Zhongtong Finance and Economics APP learned that Sihuan Pharmaceutical (00460.HK) rose by more than 6%, as of the time of publication, it rose by 6.06%, to 0.7 Hong Kong dollars, with a turnover of 33.1319 million Hong Kong dollars.